IRIS
STELLA, GIULIA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.865
AS - Asia 2.448
EU - Europa 1.910
SA - Sud America 530
AF - Africa 169
Continente sconosciuto - Info sul continente non disponibili 161
OC - Oceania 4
Totale 9.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.621
SG - Singapore 713
CN - Cina 637
IT - Italia 553
VN - Vietnam 403
BR - Brasile 394
HK - Hong Kong 318
RU - Federazione Russa 310
DE - Germania 204
IE - Irlanda 200
FR - Francia 157
FI - Finlandia 146
ZA - Sudafrica 114
GB - Regno Unito 112
CA - Canada 108
IN - India 96
BD - Bangladesh 64
AR - Argentina 54
NL - Olanda 46
MX - Messico 36
SE - Svezia 30
AT - Austria 28
IQ - Iraq 28
JP - Giappone 26
CO - Colombia 22
ES - Italia 21
CZ - Repubblica Ceca 20
IL - Israele 20
PL - Polonia 20
EC - Ecuador 19
TR - Turchia 18
ID - Indonesia 16
PK - Pakistan 16
CR - Costa Rica 15
VE - Venezuela 15
JM - Giamaica 14
MA - Marocco 14
GT - Guatemala 13
HN - Honduras 13
PH - Filippine 13
UA - Ucraina 13
LT - Lituania 12
SA - Arabia Saudita 12
CL - Cile 10
SC - Seychelles 10
NI - Nicaragua 9
AZ - Azerbaigian 8
CW - ???statistics.table.value.countryCode.CW??? 7
PR - Porto Rico 7
PY - Paraguay 7
SV - El Salvador 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
KE - Kenya 6
BE - Belgio 5
GP - Guadalupe 5
TH - Thailandia 5
UZ - Uzbekistan 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
EG - Egitto 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NP - Nepal 4
PT - Portogallo 4
AU - Australia 3
BO - Bolivia 3
DZ - Algeria 3
IR - Iran 3
KH - Cambogia 3
LK - Sri Lanka 3
LV - Lettonia 3
MU - Mauritius 3
MY - Malesia 3
PE - Perù 3
PS - Palestinian Territory 3
AL - Albania 2
CY - Cipro 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TJ - Tagikistan 2
UY - Uruguay 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
DM - Dominica 1
GY - Guiana 1
Totale 8.917
Salva come PNG Salva come JPEG
Città #
San Jose 519
Singapore 381
Council Bluffs 360
Ashburn 339
Hong Kong 299
Dallas 292
Beijing 218
Dublin 199
Chandler 148
Ho Chi Minh City 147
Los Angeles 108
Johannesburg 101
Milan 100
New York 100
Munich 98
Lauterbourg 97
Hanoi 89
Boardman 78
Turku 74
Santa Clara 73
Helsinki 68
Columbus 57
Redondo Beach 56
Moscow 47
São Paulo 44
Shanghai 42
Montreal 40
Chicago 39
Phoenix 35
Atlanta 32
Pavia 31
Buffalo 30
Rome 30
Orem 27
Da Nang 26
Falkenstein 26
Brooklyn 25
Turin 25
Chennai 24
Stockholm 24
Tokyo 24
Denver 22
Princeton 22
Nuremberg 21
London 20
Wilmington 20
Frankfurt am Main 19
Lawrence 19
Medford 17
Naples 17
Warsaw 17
Houston 16
Mexico City 16
Seattle 16
Florence 15
Jacksonville 15
North Bergen 15
Paris 15
San Francisco 15
Boston 14
Brno 13
Haiphong 13
Poplar 13
Rio de Janeiro 13
San José 13
The Dalles 13
Vienna 13
Biên Hòa 12
Düsseldorf 12
Hyderabad 12
Manchester 12
Nanjing 12
Guatemala City 11
Guangzhou 10
Shenyang 10
Toronto 10
Amsterdam 9
Ankara 9
Baghdad 9
Changsha 9
Bologna 8
Brasília 8
Bắc Ninh 8
Curitiba 8
Elk Grove Village 8
Nanchang 8
Querétaro 8
Rubiera 8
Washington 8
Baku 7
Belo Horizonte 7
Buenos Aires 7
Guayaquil 7
Managua 7
Philadelphia 7
Porto Alegre 7
Pune 7
Saluzzo 7
San Pedro Sula 7
Willemstad 7
Totale 5.280
Salva come PNG Salva come JPEG
Nome #
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 200
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 165
Athletic protocol in non-cystic fibrosis-related bronchiectasis: rationale and design of the pilot ATHOS study 150
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 148
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage 143
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin 143
Lung bronchiectasisas a paradigm of the interplay between infection and colonization on plastic modulation of the pre-metastatic niche 136
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 133
CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency 129
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 129
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy 125
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI 124
From interconnection between genes and microenvironment to novel immunotherapeutic approaches in upper gastro-intestinal cancers—A multidisciplinary perspective 122
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC 118
The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique 118
Case Report: All That Glisters Is Not* Cancer 118
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 115
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 114
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 109
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 108
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 108
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 108
Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction 106
A 28-Year-Old Man with Stridor and Dyspnea 106
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets 105
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 105
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 104
Malignant pleural mesothelioma: Genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge 104
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective 103
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience 103
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study 102
Unexpected responses to EGFR inhibition in NSCLC 102
Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms 102
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 99
The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives 97
Phenotyping sarcoidosis: a single institution retrospective analysis 97
A Rare Case of Exophiala Dermatitidis Isolation in a Patient with Non-Cystic Fibrosis Bronchiectasis: Colonization or True Infection? 95
Phenotypes and Serum Biomarkers in Sarcoidosis 93
Bayesian Networks in the Management of Hospital Admissions: A Comparison between Explainable AI and Black Box AI during the Pandemic † 90
Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and Design 88
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 88
Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection 87
Impact of Triple Inhaler Therapy on COPD Patients with Non-Small Cell Lung Cancer After Radical Surgery: A Single-Centre Retrospective Analysis 86
Molecular Diagnostic Yield and Safety Profile of Ultrasound-Guided Lung Biopsies: A Cross-Sectional Study 85
COVID-19 epidemic in a Respiratory Diseases Unit: predictor ranking and mining 85
The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review 85
Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer 85
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 84
Pulmonary Infiltrates in a Non-Cystic Fibrosis Bronchiectasis Patient: A Case Report 82
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 80
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 80
Radiomics features as predictive and prognostic biomarkers in NSCLC 80
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? 79
Asbestos and Mesothelioma 79
Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease 78
Adaptations in maximal oxygen consumption and lower-limb muscle oxygen extraction capacity following 4 months of moderate-intensity training in Parkinson's disease: a pilot study 76
Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study 76
Predictive markers associated to fibrotic evolution in hypersensitivity pneumonitis: a single institution's analysis 76
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 75
Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer 75
A non-small cell lung cancer fragile elderly patient treated with immunotherapy and non-ablative radiation therapy: a case report of a winning combination 74
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications 73
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 73
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 72
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa 72
A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab 72
Radiomics features as predictive and prognostic biomarkers in NSCLC 71
Partition analysis of data of two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience 71
A case report of primary signet ring cell carcinoma of the lung: Imaging study and literature review 69
RON tyrosine kinase mutations in brain metastases from lung cancer 69
MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin 69
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review 68
Management of severe pneumonia in respiratory non-intensive care unit: a retrospective study from a single center experience 68
Phenotyping Bronchiectasis Frequent Exacerbator: A Single Centre Retrospective Cluster Analysis 67
The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma 66
Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel delivery 63
From COPD to Smoke-Related Arteriopathy: The Mechanical and Immune–Inflammatory Landscape Underlying Lung Cancer Distant Spreading—A Narrative Review 61
Incidence of Tracheal Stenosis in ICU Hospitalized COVID-19 Patients: Results from a Prospective, Observational, Multicenter Study 60
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype 60
Evolving concepts in COPDand lung cancer: a narrative review 59
Cancers of unknown primary origin: Current perspectives and future therapeutic strategies 59
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis 58
The Role of Antifibrotic Therapy in Pulmonary Fibrosis and Lung Cancer: A Multicenter Retrospective Analysis 57
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma 56
Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes 54
Lung disease recalling paraseptal emphysema in a patient with Goltz syndrome 54
Carbon nanotubes and pleural damage: Perspectives of nanosafety in the light of asbestos experience 53
Caveolin-1 as a promoter of tumour spreading: When, how, where and why 52
Lung-Seeking Metastases 50
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 49
Telomeropathies: an emerging spectrum of disorders with important implications for patients with interstitial lung disease 47
Non-neuronal cholinergic system in airways and lung cancer susceptibility 45
Lung tumors, COPD and immune response: is epigenetics the bottom line? 43
Sex and gender differences during the lung lifespan: unveiling a pivotal impact 41
Lymph-node mapping in lung cancer staging: accuracy and limits of the current approaches 41
New Updates of the Imaging Role in Diagnosis, Staging, and Response Treatment of Malignant Pleural Mesothelioma 41
Surgical options to early-stage lung cancer: can "the less" mean "the safe"? 40
Idiopathic pulmonary fibrosis landscapes: looking glass from pathology to therapy 38
MET mutations in cancers of unknown primary origin (CUPs) 38
Reply to Althuwaybi et al 38
Totale 8.596
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.861
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 0 0 1 6 0 7 7 4 12 46
2022/2023476 39 37 1 51 37 33 0 23 222 2 26 5
2023/2024404 44 55 19 23 52 85 32 21 5 12 9 47
2024/20251.693 40 43 30 64 40 173 98 104 398 114 199 390
2025/20264.825 304 425 426 717 599 181 707 258 475 373 193 167
2026/20271.456 87 282 288 546 253 0 0 0 0 0 0 0
Totale 9.087